XML 30 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings Per Share
9 Months Ended
Jun. 27, 2020
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following is a reconciliation of the numerators and denominators of the basic and diluted per share computations for income from continuing operations (in thousands except share and per share amounts).
Three Months EndedNine Months Ended
June 27, 2020June 27, 2020
IncomeSharesPer ShareIncomeSharesPer Share
Basic EPS:
     Net income available to common shareholders$68,800  53,441  $1.29  $107,087  54,261  $1.97  
Effect of dilutive securities (1):
     Options to purchase common stock—  278  (0.01) —  339  (0.01) 
     Restricted shares—  449  (0.01) —  384  (0.01) 
Diluted EPS:
     Net income available to common shareholders$68,800  54,168  $1.27  $107,087  54,984  $1.95  
(1) The potential effects of stock awards were excluded from the diluted earnings per share calculation for the three months ended December 28, 2019, because their inclusion in a net loss period would be anti-dilutive to the earnings per share calculation.
Three Months EndedNine Months Ended
June 29, 2019June 29, 2019
IncomeSharesPer ShareIncomeSharesPer Share
Basic EPS:
     Net income available to common shareholders$46,152  57,319  $0.81  $90,346  57,021  $1.58  
Effect of dilutive securities:
     Options to purchase common stock—  412  (0.01) —  559  (0.01) 
     Restricted shares—  254  —  —  357  (0.01) 
Diluted EPS:
     Net income available to common shareholders$46,152  57,985  $0.80  $90,346  57,937  $1.56  

Options to purchase 3.1 million shares of common stock at prices ranging from $10.63 to $38.10 per share were outstanding at June 27, 2020, and options to purchase 2.6 million shares of common stock at prices ranging from $8.56 to $38.10 per share were outstanding at June 29, 2019.

For the three months ended June 27, 2020 and June 29, 2019, 0.5 million and 1.8 million options outstanding were not included in the computation of diluted earnings per share because the option exercise prices were greater than the average market price of the common shares and therefore, the effect of including these options would be antidilutive.

For the nine months ended June 27, 2020 and June 29, 2019, 1.0 million and 1.1 million options outstanding were not included in the computation of diluted earnings per share because the option exercise prices were greater than the average market price of the common shares and therefore, the effect of including these options would be antidilutive.